Introduction {#sec1-1}
============

Oxidants are free radicals that produce naturally in the body, but their overproduction can oxidize nucleic acids, proteins, and lipids and lead to oxidative stress.\[[@ref1]\] Oxidative stress is caused by enhanced oxidant markers such as reactive oxygen species (ROS) and reactive nitrogen species and/or reduction of antioxidant systems.\[[@ref2]\] Moreover, the oxidants play an important role in the pathogenesis of some diseases such as inflammation, asthma, chronic obstructive pulmonary disease, rheumatoid arthritis, and other inflammatory disorders.\[[@ref3]\]

Production of ROS by inflammatory cells plays an important role in the development of inflammatory disorders.\[[@ref4]\] Antioxidants are substances that, at low concentration, have the ability of preventing oxidation process and scavenging free radicals.\[[@ref5]\]

*Portulaca oleracea* from *Portulacaceae* may reach 40 cm in height\[[@ref6]\] and contain omega-3 fatty acids, α-linolenic acid (ALA), gamma-linoleic acid, α-tocopherol, ascorbic acid, β-carotene, and glutathione.\[[@ref7]\]

Pharmacological effects including anti-inflammatory,\[[@ref8]\] antioxidant\[[@ref9]\] chemopreventive, genoprotective,\[[@ref10]\] and antiendothelial inflammation effects\[[@ref11]\] have been reported for *P. oleracea*. The relaxant effect of the *P. oleracea* extract on tracheal smooth muscle\[[@ref12]\] and its possible mechanisms including effect on muscarinic\[[@ref13]\] and ß-adrenergic receptors\[[@ref14]\] were shown previously. The extract of the plant also showed bronchodilatory effect in asthmatic patients.\[[@ref15]\]

ALA is an essential fatty acid with several pharmacological properties.\[[@ref16]\] The therapeutic potential of ALA on cardiovascular diseases, arthritis, asthma, cancer, nervous system, bone, inflammation, and oxidative stress was also reported.\[[@ref17]\] ALA showed anti-inflammatory properties by suppressing tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6).\[[@ref18]\] Effects of ALA on oxidative stress including reducing lipid peroxidation, suppressing ROS generation, and enhancing superoxide dismutase (SOD), glutathione peroxidase (GPx), and catalase (CAT) levels were shown.\[[@ref19]\]

Antioxidant effects of the extract of *P. oleracea* and ALA as the plant constituent were evaluated in the supernatant of phytohemagglutinin-A (PHA)-stimulated and nonstimulated human lymphocytes in this study.

Materials and Methods {#sec1-2}
=====================

Plant extract and α-linolenic acid {#sec2-1}
----------------------------------

The plant was prepared from Sabzevar, Khorasan Razavi Province, Iran. A sample was deposited in the herbarium of the School of Pharmacy, Mashhad University of Medical Sciences (Herbarium No: 240-1615-12).

The hydroethanolic extract of *P. oleracea* was prepared using macerated method as previously described.\[[@ref20]\] The extract was then dissolved in complete RPMI-1640 (10% fetal bovine serum + 1% penicillin/streptomycin).

Human mononuclear cells (lymphocytes) isolation {#sec2-2}
-----------------------------------------------

Human mononuclear cells (lymphocyte) were isolated from six healthy male volunteers (mean age ± standard deviation, 24.4 ± 5.6 years; mean height, 178.5 ± 12.4 cm) exactly according to our previous studies.\[[@ref20][@ref21]\] The volunteers who have no history of inflammatory, autoimmune, and infection diseases and respiratory complaints were enrolled for this study. The study was approved by the Ethical Committee of the Mashhad University of Medical Sciences (EC-MUMs Code: 920296), and all volunteers gave their informed consent.

Experimental groups {#sec2-3}
-------------------

Oxidant and antioxidant biomarkers examined in various groups are shown in [Table 1](#T1){ref-type="table"}.

###### 

Studied groups
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Measurement of oxidant and antioxidant markers {#sec2-4}
----------------------------------------------

The levels of oxidant markers including nitric oxide (NO) and malondialdehyde (MDA) as well as antioxidant markers including thiol, SOD, and CAT were measured in the supernatant of cultured lymphocytes as described previously.\[[@ref22]\]

Statistical analysis {#sec2-5}
--------------------

Data were presented by their means ± standard error of the mean. Comparison of the results between untreated (control) and treated groups as well as between treated groups with the extract and ALA was performed using one-way analysis of variance with Tukey--Kramer *post hoc* test. *P* \< 0.05 was considered as statistical significance level.

Results {#sec1-3}
=======

Effect of lymphocyte stimulation with phytohemagglutinin-A on various parameters {#sec2-6}
--------------------------------------------------------------------------------

Lymphocyte stimulation with PHA led to a significant increase in NO and MDA levels compared to nonstimulated lymphocytes. However, values of thiol, CAT, and SOD were significantly reduced in lymphocytes after incubation with PHA in comparison with nonstimulated cells (*P* \< 0.001 for all cases) \[[Table 2](#T2){ref-type="table"}\].

###### 

Comparisons of various variables between stimulated and nonstimulated groups, between three concentrations of the extract and α-linolenic acid, and also between the extract and α-linolenic acid treated groups

![](IJPharm-50-177-g002)

Effects of dexamethasone, the extract, and α-linolenic acid on oxidant markers {#sec2-7}
------------------------------------------------------------------------------

There was no significant difference in NO and MDA values between groups treated with dexamethasone, the extract concentrations, and 5 and 15 μg/ml of ALA in nonstimulated lymphocyte media \[Figures [1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"}\]. Only MDA level was significantly decreased after treatment with dexamethasone and high concentration of ALA (45 μg/ml, *P* \< 0.001) \[[Figure 2a](#F2){ref-type="fig"}\]. However, in PHA-stimulated cells, NO and MDA level was concentration-dependently decreased in the extract- and ALA-treated cells. NO level was significantly decreased due to cells treated with 160 μg/ml of the extract as well as 15 and 45 μg/ml of ALA but MDA level showed significant decrease in treated cells with two last concentrations of the extract and ALA (*P* \< 0.01 to *P* \< 0.001). Dexamethasone treatment also significantly reduced NO and MDA levels compared to control group (*P* \< 0.001 for both cases) \[Figures [1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"}\].

![The effect of *Portulaca oleracea* and its constituent alpha-linoleic acid on nitric oxide concentration in (a) nonstimulated and (b) phytohemagglutinin-A-stimulated, cultured human lymphocytes, in control group (C), dexamethasone (D), three concentrations of the extract (10, 40, and 160 μg/ml corresponding to P10, P40, and P160), and alpha-linoleic acid (5, 15, and 45 μg/ml corresponding to ALA5, ALA15, and ALA45) treated groups (for each group,*n*= 6). Data are presented as mean ± standard error of the mean \*\**P*\< 0.01, \*\*\**P*\< 0.001 compared to Group C.^+^*P*\< 0.05 compared to dexamethasone-treated group. Statistical analyses were performed using one-way analysis of variance with Tukey--Kramer *post hoc* test](IJPharm-50-177-g003){#F1}

![The effect of *Portulaca oleracea* and its constituent alpha-linoleic acid on malondialdehyde concentration in (a) nonstimulated and (b) phytohemagglutinin-A-stimulated cultured human lymphocytes, in control group (C), dexamethasone (D), three concentrations of the extract (10, 40, and 160 μg/ml corresponding to P10, P40, and P160), and alpha-linoleic acid treated (5, 15, and 45 μg/ml corresponding to ALA5, ALA15, and ALA45) groups (for each group,*n*= 6). Data are presented as mean ± standard error of the mean \*\*\**P*\< 0.001 compared to Group C.^+++^*P*\< 0.001 compared to dexamethasone-treated group. Statistical analyses were performed using one-way analysis of variance with Tukey--Kramer *post hoc* test](IJPharm-50-177-g004){#F2}

The change of MDA level due to medium concentration of ALA was lower, but its change due to high ALA concentration was higher than the effects of the corresponding extract concentrations in nonstimulated cells (*P* \< 0.01 to *P* \< 0.001) \[[Table 2](#T2){ref-type="table"}\].

There was no significant difference in NO level between groups treated with the extract and ALA compared to treated group with dexamethasone in nonstimulated cells [Figure 1a](#F1){ref-type="fig"}\], but the effects of all extract concentrations and 5 and 15 μg/ml of ALA on MAD level were significantly lower than the effect of dexamethasone (*P* \< 0.001 for all cases) \[[Figure 2a](#F2){ref-type="fig"}\]. In stimulated cells, the effects of 10 and 40 μg/ml of the extract and 5 μg/ml of ALA on NO level as well as all concentrations of extract and ALA on MDA level were significantly lower than dexamethasone effect (*P* \< 0.05 for all cases) \[[Figure 1b](#F1){ref-type="fig"}\].

Effects of dexamethasone, the extract, and α-linolenic acid on antioxidant markers {#sec2-8}
----------------------------------------------------------------------------------

In nonstimulated cells, only treatment with 160 μg/ml of the extract and 45 μg/ml of ALA as well as dexamethasone caused significant increase in thiol \[[Figure 3a](#F3){ref-type="fig"}\], CAT \[[Figure 4a](#F4){ref-type="fig"}\], and SOD \[[Figure 5a](#F5){ref-type="fig"}\] levels compared to control group (*P* \< 0.01 to *P* \< 0.001 for all cases).

![The effect of *Portulaca oleracea* and its constituent alpha linoleic acid on Thiol concentration in (a) nonstimulated and (b) phytohemagglutinin-A-stimulated cultured human lymphocytes, in control group (C), dexamethasone (D), three concentrations of the extract (10, 40, and 160 μg/ml corresponding to P10, P40, and P160) and alpha linoleic acid treated (5, 15, and 45 μg/ml corresponding to ALA5, ALA15, and ALA45) groups (for each group,*n*= 6). Data are presented as mean ± standard error of the mean \*\*\**P*\< 0.001 compared to Group C.^+++^*P*\< 0.001 compared to dexamethasone treated group. Statistical analyses were performed using one way analysis of variance with Tukey--Kramer *post hoc* test](IJPharm-50-177-g005){#F3}

![The effect of *Portulaca oleracea* and its constituent alpha-linoleic acid on catalase concentration in (a) nonstimulated and (b) phytohemagglutinin-A-stimulated cultured human lymphocytes, in control group (C), dexamethasone (D), three concentrations of the extract (10, 40, and 160 μg/ml corresponding to P10, P40, and P160) and alpha-linoleic acid treated (5, 15, and 45 μg/ml corresponding to ALA5, ALA15, and ALA45) groups (for each group,*n*= 6). Data are presented as ± standard error of the mean \**P*\< 0.05, \*\*\**P*\< 0.001 compared to Group C.^++^*P*\< 0.01,^+++^*P*\< 0.001 compared to dexamethasone-treated group. Statistical analyses were performed using one-way analysis of variance with Tukey--Kramer *post hoc* test](IJPharm-50-177-g006){#F4}

![The effect of *Portulaca oleracea* and its constituent alpha-linoleic acid on superoxide dismutase concentration in (a) nonstimulated and (b) phytohemagglutinin-A-stimulated cultured human lymphocytes, in control group (C), dexamethasone (D), three concentrations of the extract (10, 40, and 160 μg/ml corresponding to P10, P40, and P160) and alpha linoleic acid treated (5, 15, and 45 μg/ml corresponding to ALA5, ALA15, and ALA45) groups (for each group,*n*= 6). Data presented as mean ± standard error of the mean \**P*\< 0.05, \*\**P*\< 0.01, \*\*\**P*\< 0.001 compared to Group C.^+++^*P*\< 0.001 compared to dexamethasone-treated group. Statistical analyses were performed using one-way analysis of variance with Tukey--Kramer *post hoc* test](IJPharm-50-177-g007){#F5}

In stimulated lymphocyte, concentration-dependent increase in thiol, CAT, and SOD levels was observed in treated groups with extract and ALA \[Figures [3b](#F3){ref-type="fig"}, [4b](#F4){ref-type="fig"}, and [5b](#F5){ref-type="fig"}\]. Thiol and SOD levels in groups treated with the extract concentrations and CAT level in groups treated with its two higher concentrations were statistically increased (*P* \< 0.001 for all cases). Thiol level in only treated group with high concentration of ALA but CAT and SOD levels in groups treated with its 15 and 45 μg/ml were statistically increased (*P* \< 0.05 to *P* \< 0.001). Dexamethasone treatment also caused significant increase in thiol, CAT, and SOD levels (*P* \< 0.001 for all cased) \[Figures [3b](#F3){ref-type="fig"}, [4b](#F4){ref-type="fig"}, and [5b](#F5){ref-type="fig"}\].

The effect of 45 μg/ml of ALA on thiol value was significantly lower than the effect of 160 μg/ml of the extract in nonstimulated cells (*P* \< 0.01). In stimulated lymphocytes, the effects of 15 and 45 μg/ml of ALA on thiol level were significantly less than the effects of corresponding extract concentrations (*P* \< 0.001 and *P* \< 0.01, respectively). Increased level of SOD due to treatment with ALA concentrations was significantly higher as compared to extract concentrations (*P* \< 0.05 to *P* \< 0.001) \[[Table 2](#T2){ref-type="table"}\].

The effects of all concentrations of the extract on SOD level and its two lower concentrations on thiol and CAT values were significantly lower than dexamethasone in nonstimulated cells (*P* \< 0.001 for all cases). The effect of 5 and 15 μg/ml of ALA on thiol and CAT levels and its all concentrations on SOD level was also significantly lower compared to dexamethasone effect in nonstimulated cells (*P* \< 0.001 for all cases) \[Figures [3a](#F3){ref-type="fig"}, [4a](#F4){ref-type="fig"}, and [5a](#F5){ref-type="fig"}\].

The effects of two lower concentrations of ALA on thiol and SOD levels as well as the effects of two lower concentrations of extract and ALA on CAT level were significantly lower compared to dexamethasone in stimulated cells (*P* \< 0.001 for all cases) \[Figures [3b](#F3){ref-type="fig"}, [4b](#F4){ref-type="fig"}, and [5b](#F5){ref-type="fig"}\]. Only the effects of high extract and ALA concentration on CAT were significantly greater compared to dexamethasone in stimulated cells (*P* \< 0.01 to *P* \< 0.001) \[[Figure 4b](#F4){ref-type="fig"}\].

Comparison between the effects of *Portulaca oleracea* extract and α-linolenic acid {#sec2-9}
-----------------------------------------------------------------------------------

In nonstimulated lymphocytes, the effect of 160 μg/ml of extract was significantly higher than its 10 and 40 μg/ml concentrations on thiol, CAT, and SOD levels (*P* \< 0.05 to *P* \< 0.001). The effect of the medium extract concentration on MDA value was also higher than its low concentration (10 μg/ml) (*P* \< 0.05). Significant differences between medium and high concentrations of extract were seen only in thiol and SOD levels (*P* \< 0.001 for both cases) \[[Table 2](#T2){ref-type="table"}\]. Significant difference was observed between the highest concentrations of ALA and its two lower concentrations in all measured parameters, except NO level (*P* \< 0.001 for all cases).

In PHA-stimulated cells, MDA, CAT, and SOD values in treated cells with 40 and 160 μg/ml extract concentrations were significantly higher than its 10 μg/ml concentration (*P* \< 0.05 to *P* \< 0.001). Significant differences were seen between the effect of medium and high extract concentrations on MDA, CAT, and SOD values (*P* \< 0.05 to *P* \< 0.001) \[[Table 2](#T2){ref-type="table"}\]. The effect of highest concentrations of ALA on MDA and thiol values was significantly higher compared to its other concentrations (*P* \< 0.01 to *P* \< 0.001). CAT and SOD levels were also significantly different between two higher concentrations of ALA and its low concentration (*P* \< 0.01 to *P* \< 0.001) \[[Table 2](#T2){ref-type="table"}\].

Discussion {#sec1-4}
==========

*P. oleracea* contains several constituents and previous studies reported the antiulcerogenic, antibacterial, anti-inflammatory, and antioxidant effects for the plant.

Antioxidant effects of the extract of *P. oleracea* (hydroethanolic) and ALA (the major constituent of the plant) were evaluated in the present study by the measurement of NO, MDA, CAT, SOD, and thiol levels in the cellular media of PHA-stimulated and nonstimulated human lymphocytes.

PHA is a lymphocyte mitogen with high affinity for lymphocyte surface receptors which cause an inflammatory condition due to stimulation of these cells.\[[@ref23]\] The results of the current study showed that NO and MDA levels significantly increased in PHA-stimulated lymphocytes. Other studies have shown that NO level enhanced in the supernatant of PHA- or lipopolysaccharide (LPS)/interferon gamma-stimulated lymphocytes or macrophages (RAW 264.7), which confirm the results of the present study.\[[@ref22]\]

Treatment of only PHA-stimulated lymphocytes with the extract and ALA leads to significant and concentration-dependent reduction in the antioxidant agents such as NO and MDA. In PHA-stimulated cells, only 160 μg/ml of the extract (its higher concentrations) and two higher concentrations of ALA (15 and 45 μg/ml) inhibited NO production in a concentration-dependent manner. The results also indicated that MDA level was significantly decreased after treatment with high concentration of ALA (45 μg/ml) in nonstimulated cells. In PHA-stimulated lymphocytes, treated groups with 40 and 160 μg/ml of the extract and 15 and 45 μg/ml of ALA resulted to significant reduction in MDA level.

It was shown that stimulated RAW264.7, murine macrophage cell line by LPS, treated with methanolic extract of *P. oleracea* caused reduction of NO level, concentration dependently.\[[@ref24]\] Previous studies also indicated that *P. oleracea* was able to inhibit oxidative stress response by the reduction of MDA and NO levels in colitis induced by dextran sulfate sodium in mice.\[[@ref25]\] Significant decrease in NO and MDA level in the testis, kidney, and liver of treated rats with aqueous extract of *P. oleracea* for 12 days was also observed.\[[@ref26]\] In addition, inhibitory effect of phenolic alkaloids isolated from *P. oleracea* on the formation of MDA and hydrogen peroxide-induced lipid peroxidation was shown in hydrogen peroxide-induced lipid peroxidation in rat brain homogenates.\[[@ref27]\] The effect of the plant on NO and MDA production is supported by the results of previous studies.

Significant increase in antioxidant agents such as thiol group, CAT, and SOD in PHA-stimulated lymphocytes treated by both *P. oleracea* and its constituent ALA was also observed in the present study.

It has been demonstrated that MDA content significantly reduced and antioxidant enzyme activities such as CAT increased after treatment with purslane in aging mice.\[[@ref28]\] Treatment of N-methyl-N-nitro-N-nitrosoguanidine (MNNG)-induced gastric cancer rats with purslane polysaccharides also indicated protection against MNNG-induced oxidative stress dose-dependently. Protection effect of purslane polysaccharides on the oxidative injury seems to be due to increase in SOD, CAT, and GPx activities.\[[@ref29]\] These results also support the findings of the present study showing increased antioxidant agents due to *P. oleracea* and its constituent ALA treatment.

Protective effect of ethanol extract of *P. oleracea* on the lung of mice exposed to hypoxia was demonstrated by enhanced SOD level, decreased oxidative stress, and attenuated lung inflammation.\[[@ref30]\]

Preventive effect of purslane on oxidative stress biomarkers such as SOD, CAT, GP, GSH, and MDA,\[[@ref31]\] its effect on increased activities of CAT, SOD, and GPx,\[[@ref32]\] reduction of lipid peroxidation levels, and increase in antioxidant enzyme activities\[[@ref9]\] were reported which support the findings of the present study.

Comparison of the effect of *P. oleracea* with ALA (the plant constituent) showed that the effect of medium and high concentration of the extract on MDA as an oxidant marker was lower than the corresponding concentrations of ALA in nonstimulated cells. However, the effect of high extract concentration on thiol level in nonstimulated cells and the effect of its low and medium concentrations on thiol and SOD levels in stimulated lymphocytes were significantly higher than the effect of corresponding concentrations of ALA. In fact, the antioxidant and inflammatory properties of ALA were reported as suppressing effect on TNF-α and IL-6/IL-8, reducing lipid peroxidation, and suppressing ROS generation and enhanced SOD, GPx, and CAT,\[[@ref19]\] which support the findings of the present study. The concentration of ALA in the essential oil of *P. oleracea* is 30%\[[@ref33]\] which should be lower in the extract of the plant. Therefore, the studied concentrations of ALA were half (for low concentration) to one-fourth (for high concentration) of the extract concentrations. The effect of the extract on oxidant and antioxidant markers was comparable, especially for their high concentration. Comparable effect of ALA on antioxidant and specially oxidant markers indicates that the effect of the extract of *P. oleracea* on oxidant and antioxidant markers is due to its constituent ALA. The effects of both the extract and ALA on antioxidant and oxidant markers were concentration dependent which is a further confirmation of their antioxidant property.

Dexamethasone as a positive control at the concentration of 0.1 mM showed no significant decreasing effect on NO level in nonstimulated lymphocytes while caused significant decrease in stimulated cells. It also showed significant inhibitory effect on MDA level in both nonstimulated and stimulated lymphocytes. In contrast, dexamethasone significantly increased antioxidant agents including thiol, CAT, and SOD levels in both nonstimulated and PHA-stimulated lymphocytes.

The results indicated that reduction effect of dexamethasone on NO and MDA levels and its increasing effect on thiol, CAT, and SOD levels in PHA-stimulated lymphocytes were more than most concentrations of extract and ALA, except in the case of CAT level which the effect of dexamethasone was lower than highest concentrations of extract and ALA. The effect of dexamethasone on antioxidant enzymes seen in the present study is also supported by previous studies. José *et al*. have reported that the activity of antioxidant enzymes such as CAT, GPx, and SOD increased after administering dexamethasone in adult rat lung.\[[@ref34]\] Similarly, Asayama *et al*. showed that dexamethasone enhanced SOD and CAT in the lungs and kidneys of fetal rat.\[[@ref35]\] Comparable effect of the extract of *P. oleracea* and ALA (its constituent) on oxidant and antioxidant markers also supports the antioxidant effect of the plant and ALA.

Conclusion {#sec1-5}
==========

The present study indicated that *P. oleracea* has antioxidant effects on human lymphocytes. Results demonstrate that *P. oleracea* and its constituent ALA decreased NO and MDA levels and increased antioxidant agents such as thiol, CAT, and SOD levels in human PHA-stimulated lymphocytes comparable to the effects of dexamethasone. The similar effect of the plant and its constituent ALA suggests that the antioxidant effect of *P. oleracea* is mainly due to its constituent ALA. The results suggest that this plant could be used for the treatment of various diseases associated with enhancement oxidation agents including asthma, allergic disease, and cancers as an antioxidant drug.
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